Related Experiment Video
Updated: Nov 17, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.3K
Disease Modification in Epilepsy: Behavioural Accompaniments
1Science of Health Department, School of Medicine, University "Magna Graecia" of Catanzaro, Catanzaro, Italy. erusso@unicz.it.
Current Topics in Behavioral Neurosciences
|February 16, 2021
Summary
This chapter reviews preclinical research on epilepsy comorbidities, focusing on disease modification strategies that reduce seizures and associated conditions. It evaluates current methods and potential therapeutic targets for improved epilepsy management.
Area of Science:
- Neuroscience
- Epilepsy Research
- Comorbidity Studies
Background:
- Epileptogenesis defines "disease modification" as improving epilepsy course by reducing seizure burden and comorbidities.
- Understanding the development and neurobiological causes of comorbidities is crucial for clinical and preclinical epilepsy research.
Purpose of the Study:
- To critically evaluate preclinical advancements in studying epilepsy comorbidities.
- To reconsider existing comorbidity knowledge in light of new findings.
- To analyze potential therapeutic targets for comorbidity management.
Main Methods:
- Review and critical evaluation of preclinical research on epilepsy comorbidities.
- Analysis of neurobiological mechanisms underlying comorbidity development.
- Comparison of induced and genetic epilepsy models.
Main Results:
- Preclinical research on epilepsy comorbidities has advanced significantly.
- Newer results offer revised perspectives on certain comorbidities.
- Identified neurobiological mechanisms present potential therapeutic targets.
Conclusions:
- Continued research into epilepsy comorbidities and their underlying mechanisms is essential.
- Therapeutic strategies targeting these mechanisms could improve disease modification in epilepsy.
- Understanding model differences (induced vs. genetic) is key for translational research.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
830
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
830
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
605
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
605
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
936
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
936
01:14Antiepileptic Drugs: Glutamate Antagonists
683
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
683
01:21Behavior Modification
391
Behavioral approaches have often been criticized for ignoring mental processes and focusing solely on observable behavior. However, these approaches provide an optimistic perspective for individuals seeking to change their behaviors. Rather than concentrating on intrinsic personality traits, behavioral approaches suggest that even longstanding habits can be modified by changing the reward contingencies that maintain them.
A real-world application of operant conditioning principles is applied...
A real-world application of operant conditioning principles is applied...
391
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.3K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.3K